Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Radiodermatitis
... 4.2% over the analysis period 2024-2030. Topical, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. Growth in ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis period. ... Read More
-
Condoms
... 5.8% over the analysis period 2024-2030. Natural, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in ... Read More
-
Sleep Apnea Diagnostic and Therapeutic Devices
... reach US$14.0 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the analysis ... Read More
-
Bariatric (Obesity) Surgical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.6 Billion by the ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$25.5 ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... reach US$57.7 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Stimulant, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$47.7 ... Read More
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Vertebral Compression Fracture Devices
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the ... Read More
-
Kidney Cancer Drugs
... at a CAGR of 4.8% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.8 Billion ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the end ... Read More
-
Dental Infection Control Products
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$1.3 Billion by the end ... Read More
-
Cystic Fibrosis Therapeutics
... at a CAGR of 15.2% over the analysis period 2024-2030. Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion by the end of the ... Read More
-
Gastroesophageal Reflux Disease (GERD) Therapeutics
... Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Antacids, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$3.6 Billion by ... Read More
-
Head and Neck Cancer Therapeutics
... Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. PD Inhibitors, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$2.5 Billion ... Read More
-
Ophthalmology Picture Archiving and Communication Systems
... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of the ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics
... reach US$54.0 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach ... Read More
-
Pediatric Medical Devices Market Report by Product (IVD Devices, Cardiology Devices, Anesthesia and Respiratory Care Devices, Neonatal ICU Devices, Monitoring Devices, Diagnostic Imaging Devices, Telemedicine, and Others), End User (Hospitals, Diagnostic Laboratories, Pediatric Clinics, and Others), and Region 2025-2033
... 2025-2033. Pediatrics is the branch of medicine that is involved with the health and well-being of children, adolescents, and infants. Pediatric medical devices refer to equipment that is used to treat or diagnose diseases and ... Read More
-
Amyotrophic Lateral Sclerosis Treatment Market Report by ALS Type (Sporadic ALS, Familial ALS), Drug Type (Marketed Drugs, Emerging Drugs), Diagnosis Type (Electromyogram, MRI, Blood and Urine Tests, Spinal Tap, Muscle Biopsy), Treatment (Medication, Stem Cell Therapy, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others), and Region 2025-2033
... during 2025-2033. Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene ... Read More
Research Assistance
